Abbas, M. et al. 2025. Recent FDA-approved kinase inhibitors for cancer therapy in 2025: A comprehensive review and perspectives. EXCLI Journal. 24, (Nov. 2025), 1609–1633. DOI:https://doi.org/10.17179/excli2025-8972.